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In order to investigate how IKr and IKs inhibitions affect waveforms of the ﬁeld potential in the human iPS
cell-derived cardiomyocytes sheet, we analyzed the effects of E-4031 and chromanol 293B on the
maximum upslope and peak amplitude of its second wave (n ¼ 7 for each drug). E-4031 in 10e100 nM as
well as chromanol 293B in 3e30 mM prolonged the ﬁeld-potential duration, whereas E-4031 decreased
the upslope in 10e100 nM and amplitude at 100 nM, which was not observed by chromanol 293B. Thus,
the decrease of the upslope can be used as a supplemental marker of drug-induced IKr inhibition.
© 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).Human induced pluripotent stem (iPS) cell-derived car-
diomyocytes are considered as a promising tool for evaluating the
drug-induced proarrhythmia (1e3). Field potential has been used
to detect the drug-induced electrophysiological changes in the
human iPS cell-derived cardiomyocytes sheet (2e4). While most of
the QT-prolonging drugs prolonged the ﬁeld-potential duration
(2e4), its change does not necessarily indicate which ionic chan-
nels have been modiﬁed. In order to start to overcome such limi-
tation, we tried developing a new analytical method that can
differentiate the inhibition of IKr from that of IKs, since IKr inhibition
plays a crucial role in the occurrence of drug-induced lethal ar-
rhythmias (5,6). Considering clinical observations that broad T
wave and biphasic T wave have been observed in patients with
congenital long QT syndrome type 1 and type 2, respectively (7), we
investigated how selective inhibitions of IKr and IKs affect the
waveforms of the ﬁeld potential in the human iPS cell-derived
cardiomyocytes sheet. For this purpose, we assessed the effects of
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d/4.0/).IKs, respectively (8e10), on the maximum upslope and peak
amplitude of the secondwave (dome) in the ﬁeld potential together
with its duration. We propose that the decrease of the maximum
upslope of the dome may become a supplemental marker for
predicting a drug-induced IKr inhibition.
Experiments were performed in Toho University and National
Institute of Health Sciences. The human iPS cell-derived car-
diomyocytes (batch No.1,202,320, iCells; Cellular Dynamics Inter-
national (CDI), Madison, WI, USA) were cultured as previously
described (3). Then, the surface area of 64 recording electrodes in
the probes (MED-P515A, Alpha Med Scientiﬁc, Osaka, Japan) was
coated with 2 mL of ﬁbronectin (50 mg in 1 mL of distilled water),
which were incubated at 37 C for 1 h. Next, the cardiomyocytes
were seeded onto the ﬁbronectin-coated area at a density of 3 104
cells in a 2 mL of the culturemedium, which were incubated at 37 C
with 5% CO2 for 20 h in moisture condition. Finally, each probe was
ﬁlled with 1 mL of the culture medium, and the cells were cultured
for 7e19 days before the ﬁeld-potential assay.
The electrical activity of cardiomyocytes was measured and
analyzed as previously described (3). First, cardiomyocytes sheet
was equilibrated for30min in the CO2 incubator in 1mL of freshly
replaced culture medium. Then, the probe was kept at 36e37 C
under aeration of 95% O2/5% CO2 gas with thermo-control system.
Finally, ﬁeld potentials of the cardiomyocytes sheet under sponta-
neous activity were recorded and digitized at 20 kHz using MED64nese Pharmacological Society. This is an open access article under the CC BY-NC-ND
Fig. 1. Summary of the effects of E-4031 and chromanol 293B on the ﬁeld-potential
duration corrected by Fridericia's formula (FPDcF) (A) and inter-spike interval (ISI)
(B) in human iPS cell-derived cardiomyocytes sheets. Upper panels in A and B show the
absolute values, whereas lower panels in A and B indicate their percent changes from
the baseline values. Each value represents the mean ± S.E. from 7 preparations except
for E-4031 at 100 nM, which was obtained from 3 preparations. Asterisks indicate
signiﬁcant changes from their respective baseline values. *p < 0.05, **p < 0.01.
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pass ﬁlter of 1 kHz in Toho University and 10 kHz in National
Institute of Health and Science. The waveforms, inter-spike interval
and ﬁeld-potential duration were monitored for 20 min to
conﬁrm their stability and consistency as the basal control state.
Field-potential duration was deﬁned as an interval from the initial
sharp negative deﬂection to the peak of the positive dome (3,11).
During the monitoring period, we selected several electrodes,
which would be suitable for the ﬁeld-potential assessment. After
recording the basal control state, the effects of drugs were assessed
cumulatively by adding the stock solution to the culture medium to
obtain target concentrations. The ﬁnal concentration of dimethyl
sulfoxide (DMSO) was 0.6%, which has been reported hardly to
affect ﬁeld-potential duration or inter-spike interval (11).
At each drug concentration, the ﬁeld potential was recorded for
10 min and the last 30 beats were extracted for analysis. When
early afterdepolarization and/or triggered activity were observed,
the data were removed from the statistical analysis. Early after-
depolarization was deﬁned as a deﬂection occurring at the plateau
of dome, whereas a sharp deﬂection originating from early after-
depolarization was judged as a triggered activity. Field-potential
duration was corrected with Fridericia's formula: corrected ﬁeld-
potential duration ¼ ﬁeld-potential duration/(inter-spike interval/
1000)1/3 (12). The averaged values of inter-spike interval and cor-
rected ﬁeld-potential duration were calculated from the last 30
waves at each concentration. In order to obtain maximum of the
tangential degree in upslope of the dome, “addition average”
waveformwas initially made by using the last 30 waves of the ﬁeld
potential, then the tangential degree in an section of 50 ms was
calculated sequentially with the least squares method by 5-ms step
from the bottom of the dome to its peak. A level just before the
initial sharp deﬂection was deﬁned as the baseline of the ﬁeld
potential, and the peak amplitude was measured from the baseline
level to peak of the dome.
E-4031 and chromanol 293B were obtained fromWAKO (Osaka)
and Tocris Bioscience (Bristol, UK), respectively. To prepare the
stock solutions, E-4031 was dissolved in distilled water or DMSO,
whereas chromanol 293B was done in DMSO. Fibronectin was ob-
tained from Invitrogen (Carlsbad, CA, USA).
In each experiment, one electrode that satisﬁed the following
three conditions was selected: ﬁeld potential was recorded whole
through the experiment; amplitude of the domewas the largest; and
upslope of the dome was distinguishable from the downslope. The
numbers of electrodes that satisﬁed the criteria ranged from 3 to 46
outof 64electrodes. Thedatawereexpressedasmean± S.E. Statistical
differences in the basal control values between E-4031- and Chro-
manol 293B-treated groupswere evaluated by unpaired t-test. Effects
of the drugs were evaluated with one-way repeated-measures anal-
ysis of variance (ANOVA) followed by a post-hoc test; Contrasts, for
mean values comparison between the baseline value and others. A p
value <0.05 was considered to be statistically signiﬁcant.
We evaluated the effects of E-4031 at 0, 1, 3, 10, 30 and 100 nM,
and chromanol 293B at 0, 1, 3, 10, and 30 mM on the ﬁeld potential.
The number of preparations for E-4031 at 100 nM that can be used
for the assessment was decreased from 7 to 3 due to the onset of
early afterdepolarization and/or triggered activity, which was not
induced at all by chromanol 293B. There was no signiﬁcant differ-
ence in any of the basal controls between E-4031- and chromanol
293B-treated groups.
The effects of the drugs on the corrected ﬁeld-potential duration
and inter-spike interval are summarized in Fig. 1, whereas typical
tracings of ﬁeld potential before and after the drug treatment in
each preparation are depicted in Fig. 2. E-4031 prolonged the cor-
rected ﬁeld-potential duration at 10 nM, whereas chromanol
293B did it at 3 mM (Fig. 1A, upper panels). E-4031 increased theinter-spike interval at 3 nM, whereas chromanol 293B hardly
affected it (Fig.1B, upper panels). The same results were obtained in
each drug-induced response when analyzed by using percent
changes from the baseline values (Fig. 1A and B, lower panels).
We analyzed the maximum upslope and peak amplitude of the
dome to evaluate the effects of the drugs on ﬁeld-potential wave-
forms as shown in Fig. 2. The percent changes from the baseline
values were summarized in Fig. 3. E-4031 decreased the maximum
upslope at 10 nM (Fig. 3A, left panel), whereas chromanol 293B
hardly affected it (Fig. 3A, right panel). E-4031 decreased the peak
amplitude of the dome only at 100 nM (Fig. 3B, left panel), whereas
chromanol 293B hardly affected it (Fig. 3B, right panel).
E-4031 and chromanol 293B prolonged the corrected ﬁeld-
potential duration in a concentration-dependent manner. The
former induced early afterdepolarization and triggered activity,
partly reﬂecting the pathophysiology of biphasic T wave in
congenital long QT syndrome type 2, but the latter did not induce
them. These results were in accordance with previous reports (3,4),
indicating the reliability and reproducibility of iPS cell-derived
cardiomyocytes sheets for analyzing the drug-induced responses.
Also, E-4031 prolonged the inter-spike interval, but chromanol
293B hardly affected it, indicating that the automaticity of iPS cell-
derived cardiomyocytes sheets may more depend on IKr than on IKs.
E-4031 in 10e100 nM decreased the maximum upslope of the
dome in a concentration-related manner, whereas chromanol 293B
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Fig. 2. Typical tracings of the ﬁeld-potential waveforms in the human iPS cell-derived cardiomyocytes sheets at basal control state (Control) and after the treatment with E-4031 at
30 or 100 nM, and that with chromanol 293B at 30 mM. Red lines indicate the maximum upslope of the dome of the ﬁeld potential. Low pass ﬁlter of 1 kHz was used in Toho
University (E-4031 #4-#7; and chromanol 293B #5-#7), whereas that of 10 kHz was done in National Institute of Health and Science (E-4031 #1-#3; and chromanol 293B #1-#4).
Note that vertically reversed images of the ﬁeld potentials may mimic phase 2 prolongation after chromanol 293B in comparison to phase 3 delay after E-4031.
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IKr than on IKs, which has not been reported before. On the other
hand, E-4031 at 1e30 nM hardy affected the amplitude of the
dome, and that at 100 nM decreased it in 3 preparations lacking
early afterdepolarization and triggered activity, whereas chromanol
293B hardly affected the amplitude. Thus, the amplitude may be
less sensitive than the upslope in detecting the E-4031-induced
changes in the dome. It is known that IKr does not carry any large
current early during the plateau of action potentials but shows apeak only late at the end of phase 2, whereas IKs has been shown to
carry a slowly rising current over the whole plateau duration (13).
Taken together, currently observed morphological changes in the
ﬁeld potentials may reﬂect that chromanol 293B more selectively
prolonged the plateau, and that E-4031more preferentially delayed
the end of phase 2.
In conclusion, iPS cell-derived cardiomyocytes sheets are useful
for analyzing the IKr and IKs inhibition-dependent repolarization
delay. The maximum upslope of the dome may become a
Fig. 3. Summary of the effects of E-4031 and chromanol 293B on the maximum up-
slope (Slope) (A) and peak amplitude (Amplitude) (B) of the dome of the ﬁeld potential
in human iPS cell-derived cardiomyocytes sheets. The results were shown as percent
changes from the baseline values. Each value represents the mean ± S.E. from 7
preparations except for E-4031 at 100 nM, which was obtained from 3 preparations.
Asterisks indicate signiﬁcant changes from their respective basal values. **p < 0.01.
J. Matsuo et al. / Journal of Pharmacological Sciences 128 (2015) 92e95 95supplemental marker for predicting the drug-induced IKr inhibi-
tion, which should be conﬁrmed with various IKr inhibitors besides
E-4031.
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